Call for Papers: Brain-lung crosstalk
Published in Healthcare & Nursing and General & Internal Medicine
Brain-injured patients are more likely to develop respiratory disorders and vice versa because the brain and the lungs communicate through complex bi-directional pathways which are not yet fully understood. There is a need for increased knowledge of the neuroanatomical, humoral, immune and metabolic pathways that the brain and lung use to talk to each other. Therefore, BMC Pulmonary Medicine has launched a call for papers to bring together research on the mechanisms underlying crosstalk between the brain and the lungs as well as studies investigating the epidemiology, pathophysiology and management of lung disorders in brain-injured patients to create an open access resource for all those interested in the field.
To learn more about the Collection’s scope, read the opening editorial written by the Guest Editors, which discusses recent advances, knowledge gaps and challenges faced by researchers investigating crosstalk between the brain and the lungs.
Meet the Guest Editors
Denise Battaglini: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy
Denise Battaglini is Consultant in Intensive Care at San Martino Policlinico Hospital, Genoa, Italy. Dr Battaglini is attending a PhD in Translational Medicine at the University of Barcelona, Spain. She attended two research fellowhips in pneumonia and respiratory physiotherapy at the University of Barcelona, Spain, and in neurological and pulmonary critical care at the Federal University of Rio de Janeiro, Brazil. She is involved in several research projects regarding critical care management of patients with pulmonary and neurological diseases, neurological complications of COVID-19 ARDS, ventilator-associated pneumonia, respiratory physiotherapy, and lung-and-gut microbiota in neurocritically ill patients.
Chiara Robba: Consultant in Neuro and General Intensive Care, Policlinico San Martino Hospital, Italy
James A. Town: Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Director, Medical Intensive Care Unit, Harborview Medical Center, University of Washington, Seattle, Washington.
Dr Town is an Assistant Professor of Pulmonary and Critical Care Medicine at the University of Washington. He works in the Intensive Care Units at Harborview Medical Center where he is also the Director of the Medical ICU. His clinical and academic interests are in quality improvement, post-cardiac arrest care, bedside ultrasound and medical education.
Sarah Wahlster: Section Head, Neurocritical Care in the Department of Neurology at the University of Washington, Seattle, Washington
Dr Wahlster obtained her medical degree at the Ruprecht-Karls Universität Heidelberg, followed by a post-doc in Epigenetics of Neurodegenerative Disease at Harvard Medical School. She completed neurology residency and neurocritical care fellowship at MassGeneral/Brigham in Boston, and is now the section head of Neurocritical Care in the Department of Neurology at Harborview Medical Center. Her academic interests include Mechanical Ventilation in Acute Brain Injury, Extubation and Tracheostomy Decisions in the NeuroICU, Long-Term Outcomes of Patients and their Families After Severe Acute Brain Injury, Neuroprognostication after Cardiac Arrest, Neurological Care in Resource-Limited Settings, and Medical Education.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select “Brain-lung crosstalk” from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 10 January 2024
Follow the Topic
-
BMC Pulmonary Medicine
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With Collections, you can get published faster and increase your visibility.
Technological advancements in diagnosis of pulmonary disease
BMC Pulmonary Medicine is calling for submissions to our Collection on technological advancements in the diagnosis of pulmonary disease.
The landscape of interventional pulmonary medicine is evolving rapidly, propelled by innovative technologies aimed at enhancing the minimally invasive diagnosis and treatment of lung diseases. Advances in medical technology, such as artificial intelligence, machine learning, and novel imaging techniques, are providing clinicians with unprecedented tools for diagnosing cancers and other diseases of the chest and mediastinum as well as chronic obstructive pulmonary disease (COPD) and asthma. This Collection seeks to explore the latest minimally invasive endoscopic diagnostic and therapeutic innovations that are reshaping our understanding of pulmonary diseases, thereby improving patient outcomes and fostering personalized treatment strategies.
Recent advancements, such as the development of novel disease biomarkers and enhanced diagnostic and therapeutic tools, have the potential to revolutionize clinical practices. This could lead to earlier interventions and better outcomes, and by integrating new methods and technologies, healthcare providers can improve early detection, diagnostic accuracy and efficiency, and therapies ultimately leading to better management of lung diseases and improved quality of life for patients.
Potential research topics can include but are not limited to:
- Diagnostic innovations in pulmonary disease
- New technologies in lung disease diagnosis
- Novel disease biomarkers for pulmonary conditions
- Advancements in diagnostic and disease monitoring techniques
- Horizon scanning for future diagnostic tools
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
This Collection supports research aligned with SDG 3: Good Health and Well-Being and SDG 9: Industry, Innovation and Infrastructure.
Publishing Model: Open Access
Deadline: May 21, 2027
Pediatric pulmonary disease and disorders
BMC Pulmonary Medicine is calling for submissions to our Collection on pediatric pulmonary diseases and disorders. Pediatric pulmonary diseases and disorders encompass a diverse range of conditions affecting the respiratory health of children, including asthma, cystic fibrosis, bronchitis, pulmonary vascular disease, ciliopathies, bronchopulmonary dysplasia, interstitial and diffuse lung diseases of childhood, and pulmonary infections including tuberculosis. These conditions can significantly impact a child's quality of life and overall development, making early diagnosis and effective management critical. The complexities of pediatric pulmonary disorders necessitate a multidisciplinary approach, bringing together pediatricians, pulmonologists, respiratory therapists, and researchers to develop better understanding and treatments.
Advances in the field have led to improved diagnostic techniques, targeted therapies, and a deeper understanding of the pathophysiological mechanisms underlying these conditions. With the rise of personalized medicine and innovative treatment options, the outlook for children suffering from pulmonary disorders continues to improve. Furthermore, research has highlighted the importance of addressing environmental factors, enhancing preventive measures, and fostering family-centered care in managing these conditions effectively.
Future research in pediatric pulmonary disorders may pave the way for groundbreaking treatments, including gene therapy and advanced biologics tailored to the individual needs of pediatric patients. Additionally, as our understanding of the interplay between genetics, environment, and respiratory health grows, we may see the development of novel prevention strategies that can significantly reduce the incidence and impact of these diseases in children.
Potential research topics can include but are not limited to:
- Asthma management in pediatric populations
- Advances in cystic fibrosis therapies
- Understanding bronchopulmonary dysplasia
- Pediatric pneumonia and primary ciliary dyskinesia: trends and treatments
- Pediatric interstitial lung disease
- Tuberculosis in children: challenges and strategies
This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jun 09, 2027
